308 related articles for article (PubMed ID: 34267209)
1. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients.
Chen F; Chen Z; Chen M; Chen G; Huang Q; Yang X; Yin H; Chen L; Zhang W; Lin H; Ou M; Wang L; Chen Y; Lin C; Xu W; Yin G
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):60. PubMed ID: 34267209
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.
Liang Y; Ming Q; Liang J; Zhang Y; Zhang H; Shen T
Can J Physiol Pharmacol; 2020 Nov; 98(11):803-809. PubMed ID: 32150694
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
4. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
5. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
7. Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals.
Yin G; Chen F; Chen G; Yang X; Huang Q; Chen L; Chen M; Zhang W; Ou M; Cao M; Lin H; Chen M; Xu H; Ren J; Chen Y; Chen Z
J Ovarian Res; 2022 Oct; 15(1):117. PubMed ID: 36303234
[TBL] [Abstract][Full Text] [Related]
8. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
9. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study.
Yu Z; Qin E; Cheng S; Yang H; Liu R; Xu T; Liu Y; Yuan J; Yu S; Yang J; Liang F
Sci Rep; 2022 Dec; 12(1):22184. PubMed ID: 36564416
[TBL] [Abstract][Full Text] [Related]
11. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.
Han Q; Wang J; Li W; Chen ZJ; Du Y
Microbiome; 2021 May; 9(1):101. PubMed ID: 33957990
[TBL] [Abstract][Full Text] [Related]
12. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction.
Li T; Zhang T; Gao H; Liu R; Gu M; Yang Y; Cui T; Lu Z; Yin C
Redox Biol; 2021 May; 41():101886. PubMed ID: 33592539
[TBL] [Abstract][Full Text] [Related]
13. Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.
Jobira B; Frank DN; Pyle L; Silveira LJ; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2134-44. PubMed ID: 31970418
[TBL] [Abstract][Full Text] [Related]
14. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z
BMC Med; 2023 Aug; 21(1):302. PubMed ID: 37559119
[TBL] [Abstract][Full Text] [Related]
15. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
[TBL] [Abstract][Full Text] [Related]
16. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
18. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
19. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]